EAM
TLSIW icon

Exos Asset Management’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Exos Asset Management’s Portfolio TLSIW Stock Details TLSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-167,610
Closed -$168K – 156
2024
Q1 		$168K Buy
+167,610
New +$167K 0.1% 73

Other funds holding TLSIW

Magnetar Financial
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.6B AUM 113.36% 1-Year Est. Return
Polar Asset Management Partners
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
Vestcor Inc
Vestcor Inc Fredericton, New Brunswick, Canada $4.05B AUM 34.56% 1-Year Est. Return
MP
MSD Partners New York $76.8M AUM 34.91% 1-Year Est. Return
BCM
Bluefin Capital Management New York $399M AUM 24.96% 1-Year Est. Return
Bracebridge Capital LLC
Bracebridge Capital LLC Boston, Massachusetts $5.53B AUM 25.79% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Cable Car Capital
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
Sequoia Financial Advisors
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

Exos Asset Management's TLSIW Position: Q2 2024 in Review

Exos Asset Management sold out of TriSalus Life Sciences Warrant (TLSIW) in Q2 2024, closing a stake of 167,610 shares — an estimated $168K sold.

Exos Asset Management first reported a position in TLSIW in Q1 2024 and held it in 1 quarter. The position peaked at $168K in Q1 2024. 19 funds tracked by Wall St. Rank hold TLSIW as of Q2 2024.

  • Exos Asset Management reported no remaining TriSalus Life Sciences Warrant position as of Q2 2024 after selling out during the quarter.
  • Exos Asset Management sold 167,610 TriSalus Life Sciences Warrant shares in Q2 2024, an estimated $168K.
  • Exos Asset Management first reported a position in TriSalus Life Sciences Warrant in Q1 2024 and held it in 1 quarter.
  • Exos Asset Management's TriSalus Life Sciences Warrant position peaked at $168K in Q1 2024.
  • 19 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q2 2024.

Based on Exos Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.